The global Peptide API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Peptide API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Peptide API is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Peptide API include AmbioPharm, CordenPharma, Dr. Reddy's, Bachem, Peptide Institute, Inc., PeptiStar, Piramal Pharma, Biosynth and Smaart Pharmaceutticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Peptide API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide API.
Report Scope
The Peptide API market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AmbioPharm
CordenPharma
Dr. Reddy's
Bachem
Peptide Institute, Inc.
PeptiStar
Piramal Pharma
Biosynth
Smaart Pharmaceutticals
Creative Peptides
CPC Scientific
KS-V
Shenzhen Hanyu Pharmaceutical
Shuangcheng Pharma
Chengdu Shengnuo Biopharm Co.,Ltd
Segment by Type
Hormonal Polyskin
Antibody Polypeptide
Growth Factor Polypeptide
Neuromodulatory Polypeptide
Antibacterial Peptides
Segment by Application
Antineoplastic Drugs
Immune System Drugs
Digestive System Drugs
Diabetes Drugs
Orthopedic Drugs
Obstetric Drugs
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Peptide API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Peptide API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Peptide API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Peptide API Market Overview
1.1 Product Definition
1.2 Peptide API Segment by Type
1.2.1 Global Peptide API Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 Hormonal Polyskin
1.2.3 Antibody Polypeptide
1.2.4 Growth Factor Polypeptide
1.2.5 Neuromodulatory Polypeptide
1.2.6 Antibacterial Peptides
1.3 Peptide API Segment by Application
1.3.1 Global Peptide API Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Antineoplastic Drugs
1.3.3 Immune System Drugs
1.3.4 Digestive System Drugs
1.3.5 Diabetes Drugs
1.3.6 Orthopedic Drugs
1.3.7 Obstetric Drugs
1.3.8 Others
1.4 Global Market Growth Prospects
1.4.1 Global Peptide API Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Peptide API Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Peptide API Production Estimates and Forecasts (2019-2030)
1.4.4 Global Peptide API Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Peptide API Production Market Share by Manufacturers (2019-2024)
2.2 Global Peptide API Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Peptide API, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Peptide API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Peptide API Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Peptide API, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Peptide API, Product Offered and Application
2.8 Global Key Manufacturers of Peptide API, Date of Enter into This Industry
2.9 Peptide API Market Competitive Situation and Trends
2.9.1 Peptide API Market Concentration Rate
2.9.2 Global 5 and 10 Largest Peptide API Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Peptide API Production by Region
3.1 Global Peptide API Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Peptide API Production Value by Region (2019-2030)
3.2.1 Global Peptide API Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Peptide API by Region (2025-2030)
3.3 Global Peptide API Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Peptide API Production by Region (2019-2030)
3.4.1 Global Peptide API Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Peptide API by Region (2025-2030)
3.5 Global Peptide API Market Price Analysis by Region (2019-2024)
3.6 Global Peptide API Production and Value, Year-over-Year Growth
3.6.1 North America Peptide API Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Peptide API Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Peptide API Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Peptide API Production Value Estimates and Forecasts (2019-2030)
4 Peptide API Consumption by Region
4.1 Global Peptide API Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Peptide API Consumption by Region (2019-2030)
4.2.1 Global Peptide API Consumption by Region (2019-2024)
4.2.2 Global Peptide API Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Peptide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Peptide API Consumption by Country (2019-2030)
4.3.3 United States
4.3.4 Canada
4.4 Europe
4.4.1 Europe Peptide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Peptide API Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Peptide API Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Peptide API Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Peptide API Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Peptide API Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Peptide API Production by Type (2019-2030)
5.1.1 Global Peptide API Production by Type (2019-2024)
5.1.2 Global Peptide API Production by Type (2025-2030)
5.1.3 Global Peptide API Production Market Share by Type (2019-2030)
5.2 Global Peptide API Production Value by Type (2019-2030)
5.2.1 Global Peptide API Production Value by Type (2019-2024)
5.2.2 Global Peptide API Production Value by Type (2025-2030)
5.2.3 Global Peptide API Production Value Market Share by Type (2019-2030)
5.3 Global Peptide API Price by Type (2019-2030)
6 Segment by Application
6.1 Global Peptide API Production by Application (2019-2030)
6.1.1 Global Peptide API Production by Application (2019-2024)
6.1.2 Global Peptide API Production by Application (2025-2030)
6.1.3 Global Peptide API Production Market Share by Application (2019-2030)
6.2 Global Peptide API Production Value by Application (2019-2030)
6.2.1 Global Peptide API Production Value by Application (2019-2024)
6.2.2 Global Peptide API Production Value by Application (2025-2030)
6.2.3 Global Peptide API Production Value Market Share by Application (2019-2030)
6.3 Global Peptide API Price by Application (2019-2030)
7 Key Companies Profiled
7.1 AmbioPharm
7.1.1 AmbioPharm Peptide API Corporation Information
7.1.2 AmbioPharm Peptide API Product Portfolio
7.1.3 AmbioPharm Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.1.4 AmbioPharm Main Business and Markets Served
7.1.5 AmbioPharm Recent Developments/Updates
7.2 CordenPharma
7.2.1 CordenPharma Peptide API Corporation Information
7.2.2 CordenPharma Peptide API Product Portfolio
7.2.3 CordenPharma Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.2.4 CordenPharma Main Business and Markets Served
7.2.5 CordenPharma Recent Developments/Updates
7.3 Dr. Reddy's
7.3.1 Dr. Reddy's Peptide API Corporation Information
7.3.2 Dr. Reddy's Peptide API Product Portfolio
7.3.3 Dr. Reddy's Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Dr. Reddy's Main Business and Markets Served
7.3.5 Dr. Reddy's Recent Developments/Updates
7.4 Bachem
7.4.1 Bachem Peptide API Corporation Information
7.4.2 Bachem Peptide API Product Portfolio
7.4.3 Bachem Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Bachem Main Business and Markets Served
7.4.5 Bachem Recent Developments/Updates
7.5 Peptide Institute, Inc.
7.5.1 Peptide Institute, Inc. Peptide API Corporation Information
7.5.2 Peptide Institute, Inc. Peptide API Product Portfolio
7.5.3 Peptide Institute, Inc. Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Peptide Institute, Inc. Main Business and Markets Served
7.5.5 Peptide Institute, Inc. Recent Developments/Updates
7.6 PeptiStar
7.6.1 PeptiStar Peptide API Corporation Information
7.6.2 PeptiStar Peptide API Product Portfolio
7.6.3 PeptiStar Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.6.4 PeptiStar Main Business and Markets Served
7.6.5 PeptiStar Recent Developments/Updates
7.7 Piramal Pharma
7.7.1 Piramal Pharma Peptide API Corporation Information
7.7.2 Piramal Pharma Peptide API Product Portfolio
7.7.3 Piramal Pharma Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Piramal Pharma Main Business and Markets Served
7.7.5 Piramal Pharma Recent Developments/Updates
7.8 Biosynth
7.8.1 Biosynth Peptide API Corporation Information
7.8.2 Biosynth Peptide API Product Portfolio
7.8.3 Biosynth Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Biosynth Main Business and Markets Served
7.7.5 Biosynth Recent Developments/Updates
7.9 Smaart Pharmaceutticals
7.9.1 Smaart Pharmaceutticals Peptide API Corporation Information
7.9.2 Smaart Pharmaceutticals Peptide API Product Portfolio
7.9.3 Smaart Pharmaceutticals Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Smaart Pharmaceutticals Main Business and Markets Served
7.9.5 Smaart Pharmaceutticals Recent Developments/Updates
7.10 Creative Peptides
7.10.1 Creative Peptides Peptide API Corporation Information
7.10.2 Creative Peptides Peptide API Product Portfolio
7.10.3 Creative Peptides Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Creative Peptides Main Business and Markets Served
7.10.5 Creative Peptides Recent Developments/Updates
7.11 CPC Scientific
7.11.1 CPC Scientific Peptide API Corporation Information
7.11.2 CPC Scientific Peptide API Product Portfolio
7.11.3 CPC Scientific Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.11.4 CPC Scientific Main Business and Markets Served
7.11.5 CPC Scientific Recent Developments/Updates
7.12 KS-V
7.12.1 KS-V Peptide API Corporation Information
7.12.2 KS-V Peptide API Product Portfolio
7.12.3 KS-V Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.12.4 KS-V Main Business and Markets Served
7.12.5 KS-V Recent Developments/Updates
7.13 Shenzhen Hanyu Pharmaceutical
7.13.1 Shenzhen Hanyu Pharmaceutical Peptide API Corporation Information
7.13.2 Shenzhen Hanyu Pharmaceutical Peptide API Product Portfolio
7.13.3 Shenzhen Hanyu Pharmaceutical Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Shenzhen Hanyu Pharmaceutical Main Business and Markets Served
7.13.5 Shenzhen Hanyu Pharmaceutical Recent Developments/Updates
7.14 Shuangcheng Pharma
7.14.1 Shuangcheng Pharma Peptide API Corporation Information
7.14.2 Shuangcheng Pharma Peptide API Product Portfolio
7.14.3 Shuangcheng Pharma Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Shuangcheng Pharma Main Business and Markets Served
7.14.5 Shuangcheng Pharma Recent Developments/Updates
7.15 Chengdu Shengnuo Biopharm Co.,Ltd
7.15.1 Chengdu Shengnuo Biopharm Co.,Ltd Peptide API Corporation Information
7.15.2 Chengdu Shengnuo Biopharm Co.,Ltd Peptide API Product Portfolio
7.15.3 Chengdu Shengnuo Biopharm Co.,Ltd Peptide API Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Chengdu Shengnuo Biopharm Co.,Ltd Main Business and Markets Served
7.15.5 Chengdu Shengnuo Biopharm Co.,Ltd Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Peptide API Industry Chain Analysis
8.2 Peptide API Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Peptide API Production Mode & Process
8.4 Peptide API Sales and Marketing
8.4.1 Peptide API Sales Channels
8.4.2 Peptide API Distributors
8.5 Peptide API Customers
9 Peptide API Market Dynamics
9.1 Peptide API Industry Trends
9.2 Peptide API Market Drivers
9.3 Peptide API Market Challenges
9.4 Peptide API Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
AmbioPharm
CordenPharma
Dr. Reddy's
Bachem
Peptide Institute, Inc.
PeptiStar
Piramal Pharma
Biosynth
Smaart Pharmaceutticals
Creative Peptides
CPC Scientific
KS-V
Shenzhen Hanyu Pharmaceutical
Shuangcheng Pharma
Chengdu Shengnuo Biopharm Co.,Ltd
听
听
*If Applicable.
